Novartis AG vs TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock — how do they compare? Novartis AG trades at $143.75 (market cap $268.57B), while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock trades at $213.44 (market cap $39.15B). The key difference: Novartis AG is far larger — about 6.9× TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock's market cap, and Novartis AG pays a 3.31% dividend while TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Novartis AG for 82 Days and TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock for 111 Days on average.
| NVS | TTWO | |
|---|---|---|
Market Cap | $268.57B | $39.15B |
Volume | 1,532,573 | 2,708,429 |
Sector | Health | Technology |
52-Week High | $168.62 | $262.29 |
52-Week Low | $121.80 | $189.69 |
Typical Hold Time | 82 Days | 111 Days |
Enterprise Value | $309.89B | $40.27B |
Dividend Yield | 3.31% | — |
Signals from Pluang's Aura AI — not financial advice
Novartis (NVS) trades at $143.11, down 0.12% with a bearish technical signal. The stock shows strong fundamentals with 24.67% net margin and $14B net income, though recent earnings were mixed with a Q1 miss. Analyst consensus is cautious with 68% hold ratings and a $146 target. Recent $7.8B licensing deal with China's Abogen highlights strategic moves amid pipeline setbacks.
Outlook remains balanced: valuation metrics appear reasonable (P/E 21.6) and profitability is robust, but clinical trial failures and investor scrutiny over M&A strategy pose risks. The stock trades near consensus target with institutional sentiment leaning neutral amid ongoing pipeline execution challenges.
Take-Two Interactive (TTWO) trades at $209.37, up 2.63% on the day, with a bullish technical signal and strong analyst support. The stock is supported by anticipation for Grand Theft Auto VI's November 2026 launch, though recent earnings have been mixed with a Q2 2026 miss. Fundamentals show significant revenue growth to $5.63 billion in 2025 but deep net losses, with a negative net income margin of -79.51%. Cash flow improved in 2025 due to financing activities, but operating cash flow remains negative.
The outlook is optimistic due to GTA VI's potential, with a consensus price target of $292.30 implying 40% upside. However, risks include persistent profitability challenges, high debt levels, and execution risks around the key title launch. Investor sentiment is buoyant, but the stock's valuation relies heavily on future game performance.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →Found in 1993, Take-Two consists of three wholly owned labels, Rockstar Games, 2K, and Zynga. The firm is one of the world's largest independent video game publishers on consoles, PCs, smartphones, and tablets. Take-Two's franchise portfolio is headlined by Grand Theft Auto (345 million units sold) and contains other well-known titles such as NBA 2K, Civilization, Borderlands, Bioshock, and Xcom. Zynga mobile titles include Farmville, Empires & Puzzles, and CSR Racing.
Read more on TTWO →